68 related articles for article (PubMed ID: 2265854)
21. Human leukocyte antigen B distribution in HIV discordant cohort from India.
Chaudhari DV; Chavan VR; Ahir SP; Kerkar SC; Mehta PR; Mania-Pramanik J
Immunol Lett; 2013; 156(1-2):1-6. PubMed ID: 24029662
[TBL] [Abstract][Full Text] [Related]
22. Analysis of a biallelic polymorphism in the tumor necrosis factor alpha promoter and HIV type 1 disease progression.
Knuchel MC; Spira TJ; Neumann AU; Xiao L; Rudolph DL; Phair J; Wolinsky SM; Koup RA; Cohen OJ; Folks TM; Lal RB
AIDS Res Hum Retroviruses; 1998 Mar; 14(4):305-9. PubMed ID: 9519891
[TBL] [Abstract][Full Text] [Related]
23. The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters.
Rezza G; Fiorelli V; Dorrucci M; Ciccozzi M; Tripiciano A; Scoglio A; Collacchi B; Ruiz-Alvarez M; Giannetto C; Caputo A; Tomasoni L; Castelli F; Sciandra M; Sinicco A; Ensoli F; Buttò S; Ensoli B
J Infect Dis; 2005 Apr; 191(8):1321-4. PubMed ID: 15776379
[TBL] [Abstract][Full Text] [Related]
24. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
[TBL] [Abstract][Full Text] [Related]
25. The influence of HLA genotype on AIDS.
Carrington M; O'Brien SJ
Annu Rev Med; 2003; 54():535-51. PubMed ID: 12525683
[TBL] [Abstract][Full Text] [Related]
26. HLA B51 is associated with faster AIDS progression among newly diagnosed HIV-infected individuals in Manitoba, Canada.
Keynan Y; Rueda ZV; Bresler K; Becker M; Kasper K
Int J Immunogenet; 2015 Oct; 42(5):336-40. PubMed ID: 26263514
[TBL] [Abstract][Full Text] [Related]
27. CD4 surveillance in Scotland: perspectives on severe HIV-related immunodeficiency. CD4 Collaborative Group.
AIDS; 1997 Oct; 11(12):1509-17. PubMed ID: 9342074
[TBL] [Abstract][Full Text] [Related]
28. Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS.
Scherer A; Frater J; Oxenius A; Agudelo J; Price DA; Günthard HF; Barnardo M; Perrin L; Hirschel B; Phillips RE; McLean AR;
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12266-70. PubMed ID: 15302942
[TBL] [Abstract][Full Text] [Related]
29. The predictive value of several markers in the progression to acquired immunodeficiency syndrome.
Planella T; Cortés M; Martínez-Brú C; Barrio J; Sambeat MA; González-Sastre F
Clin Chem Lab Med; 1998 Mar; 36(3):169-73. PubMed ID: 9589805
[TBL] [Abstract][Full Text] [Related]
30. [Immunogenetic disposition in HIV infection. Consequences for transfusion medicine?].
Kuntz BM; Wilhelm AM; Heimbach A; Brüster HT
Beitr Infusionther Klin Ernahr; 1987; 18():17-20. PubMed ID: 3439967
[No Abstract] [Full Text] [Related]
31. Depression, altered immunity, and health: clinical implications for psychoimmunologic processes.
Keller SE; Schleifer SJ; Bartlett JA
Res Publ Assoc Res Nerv Ment Dis; 1990; 68():179-82. PubMed ID: 1970190
[No Abstract] [Full Text] [Related]
32. Host genetic factors associated with symptomatic primary HIV infection and disease progression among Argentinean seroconverters.
Coloccini RS; Dilernia D; Ghiglione Y; Turk G; Laufer N; Rubio A; Socías ME; Figueroa MI; Sued O; Cahn P; Salomón H; Mangano A; Pando MÁ
PLoS One; 2014; 9(11):e113146. PubMed ID: 25406087
[TBL] [Abstract][Full Text] [Related]
33. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: a collaborative study.
Lamothe F; Bruneau J; Coates R; Rankin JG; Soto J; Arshinoff R; Brabant M; Vincelette J; Fauvel M
CMAJ; 1993 Oct; 149(7):945-51. PubMed ID: 8402423
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of CD4-4B4 and CD4-2H4 lymphocyte subpopulations in HIV negative homosexual, HIV seropositive and healthy subjects.
Vuillier F; Lapresle C; Dighiero G
Clin Exp Immunol; 1988 Jan; 71(1):8-12. PubMed ID: 2964959
[TBL] [Abstract][Full Text] [Related]
35. Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection.
Anderson RE; Lang W; Shiboski S; Royce R; Jewell N; Winkelstein W
Arch Intern Med; 1990 Jan; 150(1):73-7. PubMed ID: 1967523
[TBL] [Abstract][Full Text] [Related]
36. HLA haplotype and HIV infection.
Lancet; 1988 Aug; 2(8606):342-3. PubMed ID: 2899763
[No Abstract] [Full Text] [Related]
37. Serum HIV antigen and anti-P24-antibodies in 200 HIV seropositive patients: correlation with CD4 and CD8 lymphocyte subsets.
Andrieu JM; Eme D; Venet A; Audroin C; Tourani JM; Stern M; Israel-Biet D; Beldjord K; Driss F; Even P
Clin Exp Immunol; 1988 Jul; 73(1):1-5. PubMed ID: 3262463
[TBL] [Abstract][Full Text] [Related]
38. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users.
Barber Y; Rubio C; Fernández E; Rubio M; Fibla J
J Infect Dis; 2001 Nov; 184(10):1279-88. PubMed ID: 11679916
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin.
Garred P; Madsen HO; Balslev U; Hofmann B; Pedersen C; Gerstoft J; Svejgaard A
Lancet; 1997 Jan; 349(9047):236-40. PubMed ID: 9014910
[TBL] [Abstract][Full Text] [Related]
40. Determinants of HIV disease progression.
Pizzolo G; Vinante F; Morosato L; De Sabata D; Sinicco A; Raiteri R; Agostini C; Semenzato G
Lancet; 1992 Jan; 339(8785):130. PubMed ID: 1345860
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
